MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1961 to 1980 of 166,322 approvalsPage 99 of 8317

Ceftazidime and Avibactam Sodium for Injection

Approval Number: 国药准字H20253047
Registration: Jan 2, 2025

Metoclopramide Dihydrochloride Injection

Approval Number: 国药准字H20253061
Registration: Jan 2, 2025

Telmisartan Tablets

Approval Number: 国药准字H20253064
Registration: Jan 2, 2025

Clobazam Tablets

Approval Number: 国药准字HJ20250002
Registration: Jan 2, 2025

Citicoline Sodium Injection

Approval Number: 国药准字H20253057
Registration: Jan 2, 2025

Dapoxetine Hydrochloride Tablets

Approval Number: 国药准字H20253016
Registration: Jan 2, 2025

Lidocaine and Prilocaine Cream

Approval Number: 国药准字H20253006
Registration: Jan 2, 2025

Pranoprofen Eye Drops

Approval Number: 国药准字H20253051
Registration: Jan 2, 2025

Sacubitril Valsartan Sodium Tablets

Approval Number: 国药准字H20253014
Registration: Jan 2, 2025

Benidipine Hydrochloride Tablets

Approval Number: 国药准字H20253019
Registration: Jan 2, 2025

Telmisartan Tablets

Approval Number: 国药准字H20253063
Registration: Jan 2, 2025

Mupirocin Ointment

Approval Number: 国药准字H20253011
Registration: Jan 2, 2025

Cefoperazone Sodium and Sulbactam Sodium for Injection

Approval Number: 国药准字H20253029
Registration: Jan 2, 2025

Hemofiltration Replacement Fluid of Sodium Citrate

Approval Number: 国药准字H20253005
Registration: Jan 2, 2025

双黄消炎片

Approval Number: 国药准字Z19994053
Registration: Dec 31, 2024

Sodium Bicarbonate Tablets

Approval Number: 国药准字H33021077
Registration: Dec 31, 2024

Compound Glycyrrhiza Oral Solution

Approval Number: 国药准字H20054241
Registration: Dec 31, 2024

Metamizole Sodium Tablets

Approval Number: 国药准字H33020744
Registration: Dec 31, 2024

苦参栓

Approval Number: 国药准字Z52020368
Registration: Dec 31, 2024

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.